The impact of concealable chronic health conditions on college students’ academic outcomes: A two-wave study

College students ( N = 125) with concealable chronic health conditions (CCHCs) completed online surveys at the beginning and end of the semester assessing stigma experiences and academic outcomes. Correlations showed stigma, alienation, and lack of campus fit were associated with greater illness-related academic interference ( ps < 0.001), negative academic self-comparison ( ps < 0.001), academic anxiety ( ps < 0.001), academic dissatisfaction ( ps < 0.001), and lower expected grades (except alienation; ps < 0.001–0.03) over time. Hierarchical multiple regressions identified a lack of campus fit as an important predictor across academic outcomes ( ps < 0.001–0.019). Students with CCHCs face health- and stigma-related challenges that can interfere with academic performance.

Does Stigma Moderate the Efficacy of Mental- and Behavioral-Health Interventions? Examining Individual and Contextual Sources of Treatment-Effect Heterogeneity

In this article, we argue that stigma may be an important, but heretofore underrecognized, source of heterogeneity in treatment effects of mental- and behavioral-health interventions. To support this hypothesis, we review recent evidence from randomized controlled trials and spatial meta-analyses suggesting that stigma may predict not only who responds more favorably to these health interventions (i.e., individuals with more stigma experiences), but also the social contexts that are more likely to undermine intervention effects (i.e., communities with greater structural stigma). By highlighting the potential role of personal and contextual stigma in shaping response to interventions, our review paves the way for additional research.

Participatory Methods for Stigma Reduction with HIV-Affected Families

HIV stigma contributes to risks for poor health; these risks are exacerbated by additional stigmas of race, gender, sexual orientation, and substance abuse history. As women continue to be infected by HIV and as people with HIV are living longer, their children, most of whom are not HIV infected, are affected by their parent’s HIV status. Children may feel stigma as acutely as their HIV-positive (HIV+) parents, contributing to the children’s vulnerability. Children of HIV+ mothers have more emotional problems, disrupted relationships, and poor school outcomes than those whose mothers are not living with HIV. As we learn about stigma’s impact beyond the individual, we are compelled to respond systemically within families to reduce future generations’ vulnerability to HIV and other risks. Based on a line of inquiry with HIV-affected teens about their stigma experiences, our multidisciplinary team discovered stigma’s impact on our ability, not only to study stigma, but to engage parents and especially their children in services and research. We draw on these findings and the literature on community-based participation to contend that participatory methods have value, not only for research and program development, but in reducing the impact of stigma with our HIV-affected partners. The participatory process is as important to stigma reduction as knowledge and service development outcomes. Participatory methods can expand our potential for breaking the cycle of intergenerational vulnerability by strengthening family skills and capacity and enhancing self-worth so those affected by HIV are empowered to overcome stigma’s impact.

COVID-19-related stigma and its sociodemographic correlates: a comparative study

Background Coronavirus disease 2019 (COVID-19) is closely associated with physical and mental health problems; however, little is known about the severity of stigma caused by COVID-19 among its survivors. Thus, the aim of this study was to compare differences in stigma experiences of COVID-19 survivors versus healthy controls after the COVID-19 outbreak peak in China. Methods This cross-sectional study comprised 154 COVID-19 survivors and 194 healthy controls recruited through consecutive and convenience sampling methods, respectively. COVID-19 related stigma was measured by the Social Impact Scale (SIS). Stigma differences between the two groups were compared with analysis of covariance (ANCOVA) and a generalized linear model (GLM) was used to identify independent correlates of COVID-19-related stigma in this study. Results Compared with healthy controls, COVID-19 survivors reported more overall stigma (F(1,347) = 60.82, p < 0.001), and stigma in domains of social rejection (F(1,347) = 56.54, p < 0.001), financial insecurity (F(1,347) = 19.96, p < 0.001), internalized shame (F(1,347) = 71.40, p < 0.001) and social isolation (F(1,347) = 34.73, p < 0.001). Status as a COVID-19 survivor, having family members infected with COVID-19, being married, economic loss during the COVID-19 pandemic, and depressive symptoms were positively associated with higher overall stigma levels (all p values < 0.05). Conclusion COVID-19-related stigma is commonly experienced among COVID-19 survivors even though the outbreak has been well-contained in China. Routine assessment of stigma experiences should be conducted on COVID-19 survivors and appropriate psychological assistance, public education, and anti-stigma campaigns and policies should be enforced to reduce stigma within this vulnerable subpopulation.